National Comprehensive Cancer Network

NCCN Announces Research Funding for Biomarker-Directed Therapy in Metastatic Colorectal Cancer

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) recently announced new grants awarded to improve quality initiatives focused on optimizing biomarker-directed therapy in metastatic colorectal cancer. …

NCCN Announces Research Funding for Biomarker-Directed Therapy in Metastatic Colorectal Cancer Read More